Wayland Group Corp. (CSE:WAYL; FWB:75M; OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to welcome Mr. Clay Horner and Mr. Rudolph (Rudi) Hilti to the board, which will strengthen and improve corporate governance, global strategy, finance, and M&A expertise. These latest appointments demonstrate management’s continued commitment to ensuring measured growth of Wayland Group’s global expansion and to fill vacancies left on the board earlier this year. Additionally, Paul Pathak has now been appointed Chairman of the Board.
“Clay’s unmatched experience in acquisitions and unique ability to unlock shareholder value provides Wayland with a strategic advantage as we build a truly global business,” stated Ben Ward, CEO. “Rudi brings a unique perspective as a global citizen, from Lichtenstein, with a passion for global transformation through sustainable solutions.”
Clay Horner is a principal of HBH Strategic Advisors which consults on significant business and corporate matters for several large private equity firms and domestic and international corporations. Until February 2018, Clay was a senior partner of law firm Osler, Hoskin& Harcourt LLP. His practice included many of Canada’s most significant M&A transactions with an aggregate value in excess of $300 billion over the past 25 years, including landmark Canadian transactions and cross border transactions with the United States, the United Kingdom, France, Germany, Italy, China, Russia and South Africa. He was the Chairman of Osler and Chairman of the Business Law Department for almost two decades. In 2011, he was named one of the 15 most influential M&A lawyers in the world by the International Bar Association. He has a BA from Queens University, an LLB from the University of Toronto Law School and an LLM from the Harvard Law School.
Rudi Hilti is an entrepreneur and a visionary from the Principality of Liechtenstein, a German speaking microstate in Central Europe. Rudi is a global citizen, a responsible optimist and a change maker who invests his financial and emotional resources exclusively into passion projects that help to make the world a sustainable and better place genuinely. Rudi’s experience includes co-founding of the HUS Institute, a global think tank and Deals Advisory with Price Waterhouse Coopers, Zurich. Rudi holds a Master of Finance and Accounting from HSG in Switzerland.
“There are multiple reasons why humanity should foster the rehabilitation of cannabis as a resource. I’m passionate about system change and sustainable solutions, I am very excited to join the Wayland journey.” Stated Mr. Hilti.
Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.
About Wayland Group
Wayland is a vertically integrated cultivator and processor of cannabis. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation, and distribution business under federal licenses from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland. Wayland is currently undertaking an expansion of its cultivation and support facilities in Canada and will continue to pursue new opportunities globally.
Forward Looking Information
This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
For more information about Wayland, please visit our website at www.waylandgroup.com
Media Inquiries: email@example.com
Corporate Headquarters (Canada)
Wayland Group Corp. (Toronto)
845 Harrington Court, Unit 3
Burlington Ontario L7N 3P3
European Headquarters (Germany)
Thierschstrasse 3, 80538 Munchen, Deutschland
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/